Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer
Sponsor and Collaborators
Southwest Oncology Group
National Cancer Institute (NCI)
Principal Investigator
Edward M. Messing, MD, FACS, James P. Wilmot Cancer Center
David P. Wood, MD, University of Michigan Cancer Center
ClinicalTrials.gov Identifier
NCT00445601